CYP19A1 and Alzheimer disease: Rodent models for AD and those where such models have been combined with ones lacking Cyp19 gene provide robust support that normal expression of aromatase, especially within the neurons, is associated with less risk for AD-like cognitive impairments (190, 192, 193), and that females might be more vulnerable than males (190).